期刊文献+

A survey on biomarker identification based on molecular networks 被引量:1

A survey on biomarker identification based on molecular networks
原文传递
导出
摘要 Identifying biomarkers for accurate diagnosis and prognosis of diseases is important for the prevention of disease development. The molecular networks that describe the functional relationships among molecules provide a global view of the complex biological systems. With the molecular networks, the molecular mechanisms underlying diseases can be unveiled, which helps identify biomarkers in a systematic way. Results: In this survey, we report the recent progress on identifying biomarkers based on the topology of molecular networks, and we categorize those biomarkers into three groups, including node biomarkers, edge biomarkers and network biomarkers. These distinct types of biomarkers can be detected under different conditions depending on the data available. Conclusions: The biomarkers identified based on molecular networks can provide more accurate diagnosis and prognosis. The pros and cons of different types of hiomarkers as well as future directions to improve the methods for identifying biomarkers are also discussed. Identifying biomarkers for accurate diagnosis and prognosis of diseases is important for the prevention of disease development. The molecular networks that describe the functional relationships among molecules provide a global view of the complex biological systems. With the molecular networks, the molecular mechanisms underlying diseases can be unveiled, which helps identify biomarkers in a systematic way. Results: In this survey, we report the recent progress on identifying biomarkers based on the topology of molecular networks, and we categorize those biomarkers into three groups, including node biomarkers, edge biomarkers and network biomarkers. These distinct types of biomarkers can be detected under different conditions depending on the data available. Conclusions: The biomarkers identified based on molecular networks can provide more accurate diagnosis and prognosis. The pros and cons of different types of hiomarkers as well as future directions to improve the methods for identifying biomarkers are also discussed.
出处 《Frontiers of Electrical and Electronic Engineering in China》 CSCD 2016年第4期310-319,共10页 中国电气与电子工程前沿(英文版)
基金 This work was partly supported by the National Nature Science Foundation of China (Nos. 91530321, 61390513, 61602347 and 61572363), and the Fundamental Research Funds for the Central Universities.
关键词 BIOMARKER molecular network MODULE PATHWAY biomarker molecular network module pathway
  • 相关文献

参考文献1

二级参考文献67

  • 1Hood L, Flores M. A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. N Biotechnol, 2012, 29: 613-624.
  • 2Hood L, Friend SH. Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol, 2011, 8: 184-187.
  • 3Auffray C, Charron D, Hood L. Predictive, preventive, personalized and participatory medicine: back to the future. Genome Med, 2010, 2: 57.
  • 4Zeng T, Sun SY, Wang Y, Zhu H, Chen L. Network biomarkers reveal dysfunctional gene regulations during disease progression. FEBS J, 2013, doi:10.1111/febs.12536.
  • 5Zhong Q, Simonis N, Li QR, Charloteaux B, Heuze F, Klitgord N, Tam S, Yu H, Venkatesan K, Mou D, Swearingen V, Yildirim MA, Yan H, Dricot A, Szeto D, Lin C, Hao T, Fan C, Milstein S, Dupuy D, Brasseur R, Hill DE, Cusick ME, Vidal M. Edgetic perturbation models of human inherited disorders. Mol Syst Biol, 2009, 5: 321.
  • 6Zhang W, Zeng T, Chen L. EdgeMarker: identifying differentially correlated molecule pairs as edge-biomarkers. J Theor Biol, 2014, doi:10.1016/j.jtbi.2014.05.041.
  • 7Chen L, Liu R, Liu ZP, Li M, Aihara K. Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers. Sci Rep, 2012, 2: 342.
  • 8Liu R, Li M, Liu ZP, Wu J, Chen L, Aihara K. Identifying critical transitions and their leading biomolecular networks in complex diseases. Sci Rep, 2012, 2: 813.
  • 9Liu R, Wang X, Aihara K, Chen L. Early diagnosis of complex diseases by molecular biomarkers, network biomarkers, and dynamical network biomarkers. Med Res Rev, 2013, doi:10.1002/med.21293.
  • 10Liu R, Yu X, Liu X, Xu D, Aihara K, Chen L. Identifying critical transitions of complex diseases based on a single sample. Bioinformatics, 2014, doi:10.1093/bioinformatics/btu084.

共引文献4

同被引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部